GigCapital5 (NYSE:GIA) versus Endonovo Therapeutics (OTCMKTS:ENDV) Financial Survey

Endonovo Therapeutics (OTCMKTS:ENDV) and GigCapital5 (NYSE:GIA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Valuation & Earnings

This table compares Endonovo Therapeutics and GigCapital5″s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Endonovo Therapeutics	$140,000.00	2.83	$6.93 million	N/A	N/A
GigCapital5	N/A	N/A	-$2.77 million	N/A	N/A

Endonovo Therapeutics has higher revenue and earnings than GigCapital5.

Profitability

This table compares Endonovo Therapeutics and GigCapital5’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Endonovo Therapeutics	4,911.97%	-29.58%	755.18%
GigCapital5	N/A	N/A	-14.85%

Volatility and Risk

Endonovo Therapeutics has a beta of -1.88, meaning that its stock price is 288% less volatile than the S&P 500. Comparatively, GigCapital5 has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings for Endonovo Therapeutics and GigCapital5, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Endonovo Therapeutics	0	0	0	0	N/A
GigCapital5	0	0	0	0	N/A

Institutional and Insider Ownership

27.3% of GigCapital5 shares are held by institutional investors. 5.6% of Endonovo Therapeutics shares are held by company insiders. Comparatively, 75.4% of GigCapital5 shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

About Endonovo Therapeutics

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

About GigCapital5

GigCapital5, Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Palo Alto, California.GigCapital5, Inc operates as a subsidiary of GigAcquisitions5, LLC